CTMX vs NGNE: stock comparison and AI forecast
Cytomx Therapeutics, Inc. (CTMX) and Neurogene Inc. (NGNE) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CTMX Cytomx Therapeutics, Inc.
- Market Cap
- $510M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
NGNE Neurogene Inc.
- Market Cap
- $534M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- CTMX and NGNE have similar market capitalizations ($510M and $534M).
- NGNE carries 0.13 times debt per unit of equity, against 0.12 times for CTMX.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CTMX | NGNE |
|---|---|---|
| Market Cap | $510M | $534M |
| P/B Ratio | 1.59x | 2.46x |
| EPS | $-0.61 | $-5.03 |
| Book Value/Share | $1.47 | $10.85 |
| Revenue/Share | $0.08 | – |
| FCF/Share | $-0.38 | $-4.38 |
Profitability & Margins
| Metric | CTMX | NGNE |
|---|---|---|
| ROE | – | -51.2% |
| ROA | – | -45.5% |
| ROIC | – | -54.5% |
| Operating Margin | -120.9% | – |
| EBT Margin | -110.2% | – |
| Tax Rate | -0.3% | – |
Financial Health
| Metric | CTMX | NGNE |
|---|---|---|
| Current Ratio | 9.36x | 10.64x |
| D/E Ratio | 0.12x | 0.13x |
| Financial Leverage | – | 1.13x |
| Interest Coverage | -41.8x | 6882.5x |
| Working Capital | $333M | $207M |
Cash Flow
| Metric | CTMX | NGNE |
|---|---|---|
| Operating Cash Flow | -$82M | -$87M |
| Free Cash Flow | -$82M | -$88M |
| Capital Spending | -$70K | -$890K |
| FCF/Sales | -450.7% | – |
| CapEx/Sales | 0.4% | – |
Operational Efficiency
| Metric | CTMX | NGNE |
|---|---|---|
| Receivables Turnover | 0.5x | – |
| Fixed Assets Turnover | 17.0x | – |
| Days Sales Outstanding | 748 days | – |
Income Statement
| Metric | CTMX | NGNE |
|---|---|---|
| Total Revenue | $18M | – |
| Operating Income | -$87M | -$121M |
| Net Income | – | -$111M |
| R&D Expense | $73M | $88M |
Dividend & Shareholder Information
| Metric | CTMX | NGNE |
|---|---|---|
| Shares Outstanding | 218M | 20M |
| EPS Growth | -208.9% | – |
CTMX vs NGNE: stock comparison and AI forecast
Which is bigger, CTMX or NGNE?
CTMX and NGNE have similar market capitalizations ($510M and $534M).
Which one does Intratio's AI model rank higher, CTMX or NGNE?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.